本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enliven Treateutics

54.32
-1.9100-3.40%
盤後54.320.00000.00%19:56 EDT
成交量:99.58萬
成交額:5,444.96萬
市值:39.80億
市盈率:-32.42
高:57.00
開:57.00
低:54.12
收:56.23
52周最高:62.32
52周最低:14.79
股本:7,327.08萬
流通股本:6,172.59萬
量比:0.94
換手率:1.61%
股息:- -
股息率:- -
每股收益(TTM):-1.6753
每股收益(LYR):-1.8300
淨資產收益率:-15.31%
總資產收益率:-11.00%
市淨率:4.45
市盈率(LYR):-29.68

資料載入中...

2024/05/14

重要事件披露

Form 8-K - Current report
2024/04/27

SEC問詢函

Form CORRESP - Correspondence
2024/04/19

SEC問詢函

Form CORRESP - Correspondence
2024/04/15

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/11

重要事件披露

Form 8-K - Current report
2024/04/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/09

重要事件披露

Form 8-K - Current report
2024/04/04

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/19

重要事件披露

Form 8-K - Current report
2024/03/14

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans